Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

Delayed Data
As of Jan 17
 -0.20 / -0.50%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 44.00, with a high estimate of 89.00 and a low estimate of 34.00. The median estimate represents a +11.39% increase from the last price of 39.50.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -92.09%
Growthannually -42.89%


Growthquarterly 6.14%
Growthannually 10.82%
Key to the earnings and sales forecast charts.